NCT07356245 2026-01-21
Ruxolitinib Maintenance Post-Hematopoietic Stem Cell Transplant T-Cell Lymphoma
Ohio State University Comprehensive Cancer Center
Phase 2 Recruiting
Ohio State University Comprehensive Cancer Center
National Cancer Institute (NCI)
National Institutes of Health Clinical Center (CC)